scispace - formally typeset
B

Bastiaan E. de Galan

Researcher at Maastricht University

Publications -  107
Citations -  8886

Bastiaan E. de Galan is an academic researcher from Maastricht University. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 20, co-authored 67 publications receiving 7942 citations. Previous affiliations of Bastiaan E. de Galan include Radboud University Nijmegen Medical Centre & Royal Prince Alfred Hospital.

Papers
More filters
Journal ArticleDOI

Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes

Lian A. van Meijel, +3 more
- 16 Aug 2021 - 
TL;DR: In this paper, the authors tested the hypothesis that short-term use of dapagliflozin may improve awareness of hypoglycaemia in people with Type 1 diabetes and IAH.
Journal ArticleDOI

Iedereen met diabetes heeft recht op bloeddrukverlaging

Bastiaan E. de Galan, +2 more
- 01 Dec 2008 - 
TL;DR: The results of this study suggest that blood pressure lowering treatment is to be recommended for everyone with diabetes at sufficient risk, and recommend revision of the Dutch guidelines that agree with these findings.
Journal ArticleDOI

Effectiveness of educational and behavioural interventions for reducing fear of hypoglycaemia among adults with type 1 diabetes: Systematic review and meta‐analyses

Hannah Chatwin, +6 more
- 17 Feb 2023 - 
TL;DR: In this article , the effectiveness of educational and/or behavioural interventions in reducing fear of hypoglycaemia among adults with Type 1 diabetes was evaluated. But, the authors did not evaluate the effect of these interventions on overall health.
Journal ArticleDOI

Effect of Hypoglycemia on Heart Rate Variability in People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia

Mats Koeneman, +5 more
- 15 Apr 2021 - 
TL;DR: In this article, a device alerting to hypoglycemia was proposed for people with impaired awareness of hypocemia (IAH) who are at elevated risk of severe, potentially hazardous, hypo-cemia.
Journal ArticleDOI

Long-term Evaluation of Spinal Cord Stimulation in Patients With Painful Diabetic Polyneuropathy: An Eight-to-Ten-Year Prospective Cohort Study.

Xander Zuidema, +7 more
- 01 Dec 2022 - 
TL;DR: In this article , the authors evaluated the long-term effects of spinal cord stimulation (SCS) in patients with painful diabetic polyneuropathy (PDPN) and showed that SCS can remain an effective treatment in the long term to reduce pain intensity in a sub-group of patients with PDPN who still had an SCS device implanted after eight years.